Human papillomavirus infection and cervical cancer prevention in India, Bangladesh, Sri Lanka and Nepal.
about
Current global status & impact of human papillomavirus vaccination: Implications for IndiaEpidemiology and prevention of human papillomavirus and cervical cancer in sub-Saharan Africa: a comprehensive review.Genital human papillomavirus infection among women in Bangladesh: findings from a population-based surveyPrevalence and predictors of colposcopic-histopathologically confirmed cervical intraepithelial neoplasia in HIV-infected women in India.Oncogenic HPV among HIV infected female population in West Bengal, IndiaHuman papillomavirus prevalence and type-distribution in women with cervical lesions: a cross-sectional study in Sri LankaIntellectual property, technology transfer and manufacture of low-cost HPV vaccines in India.Global challenges of implementing human papillomavirus vaccines.Cervical cancer screening and HPV genotype distribution among asymptomatic patients of Karachi Pakistan.Expression of codon optimized major capsid protein (L1) of human papillomavirus type 16 and 18 in Pichia pastoris; purification and characterization of the virus-like particles.External Beam Therapy in a Four-Field Box Technique with Paclitaxel versus a Two-Field Technique with Cisplatin in Locally Advanced Carcinoma Cervix: A Phase II Monocentric Trial.High risk human papillomavirus type 16 and 18 infection in the cervical lesions of women with epithelial cell abnormality in Pap smear: A cytohistomorphologic association in Bangladeshi womenImmunogenicity and HPV infection after one, two, and three doses of quadrivalent HPV vaccine in girls in India: a multicentre prospective cohort study.Human papillomavirus: science and technologies for the elimination of cervical cancer.Cervical cancer control in India: taking evidence to action.Distribution of human papillomavirus genotypes in archival cervical tissue from women with cervical cancer in urban Sri Lanka.[Translation of knowledge on cervical cancer: is there a gap between research on causes and research on patient care?].Prevalence of human papillomavirus infection among women in rural Nepal.Immunogenicity and safety of human papillomavirus-16/18 AS04-adjuvanted cervical cancer vaccine in healthy Indian women.Histopathology of Cervical Cancer and Arsenic Concentration in Well Water: An Ecological Analysis.Ethnic Variations in Perception of Human Papillomavirus and its Vaccination among Young Women in Nepal .Performance of visual inspection with acetic acid and human papillomavirus testing for detection of high-grade cervical lesions in HIV positive and HIV negative Tanzanian women.Screening for cervical neoplasia in Bangladesh using visual inspection with acetic acid.Evaluation of visual inspection with acetic acid and Lugol's iodine as cervical cancer screening tools in a low-resource setting.Evaluation of cervical screening in rural North India.Human papillomavirus genotype distribution in cervical cancer biopsies from Nepalese women.Prevalence of human papillomavirus types in cervical lesions from women in rural Western India.Human papillomavirus vaccine for cancer cervix prevention: Rationale & recommendations for implementation in India.Knowledge and Acceptance of Human Papillomavirus Vaccine for Cervical Cancer Prevention Among Urban Professional Women in Bangladesh: A Mixed Method Study.
P2860
Q28079776-8C016B06-0B3B-40F3-A3E5-A6F2AA100242Q30227546-EE624251-BBDB-4A51-B339-4477DE2EAA36Q30856793-7152C711-3C71-44D0-8F19-C7AAB97D9E7DQ33523800-CEB2629D-431C-4C27-9E72-C35991744FFDQ33850433-9CA61FA7-6EDF-4FF3-98A5-E93A1397CEF2Q35099979-F77894CC-034C-4BF4-827C-0592CC464B32Q35112350-82628040-E90E-4BC0-B6B4-F803B209DEA4Q35128768-F3F3F6F6-0003-4F60-A2AF-A8A018051E98Q35796666-10CC4E3C-A401-45E1-8EFB-F1DD324D66E8Q36426605-1E144614-0397-4F30-9627-968C627359A1Q36546407-C731AD00-5FEF-4E7D-9B3E-62772B31E088Q37108484-B3D91DB5-84F3-4BFF-BFA6-8769D4C03E2FQ37710523-B0CBCE24-B446-4290-98CB-9C783FF138A8Q37901056-01D2DE1D-C496-4469-A10A-DF40E14E65A0Q38007296-7D584270-1781-47B5-9E0E-23EE6BFD1565Q38408633-7289FD21-0533-4715-99C3-15108343B2EDQ38478815-9DD377EE-297F-4511-BB00-B986D3404394Q39313728-27C4BE27-AF80-40D2-A880-950247F62807Q40365628-BAFC2C50-CE0D-47E9-9490-891ADFB7C4D8Q41922882-3E0FF115-31F2-41C4-92FD-431999375791Q42013807-39BB7378-629E-467D-B0B4-27007F8A53DFQ42245169-84AC3D0B-8864-437D-9219-ABB55A3C477BQ42950537-57B67EA2-EB5A-4B90-BC7F-17F3D377CBB7Q43223048-B99A5895-F5C5-4DA1-9BF5-346307321ADEQ46129804-34BD163F-791B-4F6C-9287-5C6A5465AA34Q47548474-27420E04-A3CA-4589-9E18-5558B48E4FC4Q47764270-27E90E3B-232F-47F8-A759-DBC3D1D1CC5BQ49537306-5BA410C8-2BCE-49D2-9889-5E3D58039A27Q55039828-0E370885-4C0D-47E8-A96B-16A2EE762AC0
P2860
Human papillomavirus infection and cervical cancer prevention in India, Bangladesh, Sri Lanka and Nepal.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Human papillomavirus infection ...... ngladesh, Sri Lanka and Nepal.
@en
Human papillomavirus infection ...... ngladesh, Sri Lanka and Nepal.
@nl
type
label
Human papillomavirus infection ...... ngladesh, Sri Lanka and Nepal.
@en
Human papillomavirus infection ...... ngladesh, Sri Lanka and Nepal.
@nl
prefLabel
Human papillomavirus infection ...... ngladesh, Sri Lanka and Nepal.
@en
Human papillomavirus infection ...... ngladesh, Sri Lanka and Nepal.
@nl
P2093
P921
P1433
P1476
Human papillomavirus infection ...... ngladesh, Sri Lanka and Nepal.
@en
P2093
Aarati Shah
Bhagwan M Nene
K S Ashrafunnessa
Partha Basu
Patti E Gravitt
Pulikattil O Esmy
Rengaswamy Sankaranarayanan
Yasantha Ariyaratne
P304
P356
10.1016/J.VACCINE.2008.05.005
P407
P478
26 Suppl 12
P577
2008-08-01T00:00:00Z